Johns Hopkins experts are leaders in the identification and treatment of genitourinary cancers, including testicular cancer.
Testicular Cancer Experts
Testicular cancer experts from the Brady Urological Institute and Kimmel Cancer Center collaborate to provide world-class care, using the most innovative and function-preserving surgical techniques and unparalleled knowledge of chemotherapy agents and radiation treatments.
About Testicular Cancer
Testicular cancer is one of the most common cancers in young men between the ages of 15 and 34 and quite rare after age 40. Caucasian men are affected more than men of other races. The cure rate is very high when testicular cancer is diagnosed and treated early.
Most testicular cancers are found by men themselves. Whereas any testicular abnormality is cause for concern, an actual lump inside the testis is frequently a sign of cancer and should be evaluated immediately. The earlier testicular cancer is identified, the greater the likelihood of a cure.
Physicians rely on the diagnostic test, transillumination, in which a bright light is shined through the scrotum; tumors will appear opaque, whereas other abnormalities such as hydrocele or spermatocele will appear translucent. Sonography is another test that confirms a testicular tumor. The only way to confirm the presence of cancer is to remove the testicle surgically and examine a tissue sample under the microscope. Ultrasound, CT scans and X-ray are used to determine whether the cancer has spread beyond the testicle. Blood tests for specific biochemical markers of testicular cancer can be used to track the response to treatment and detect the recurrence of cancer.
In most cases, surgery is performed to remove the testicle. Subsequent treatment depends on the extent and cell type of the tumor. Often, radiation, chemotherapy, or more surgery also are recommended. Johns Hopkins urologists are particularly sensitive to the emotional and physiologic impact of testicular cancer.